Unified Patent Court (UPC) analytics are now available. Check here

Law FirmOpposition Filing Analysis

The comprehensive analysis of Ter Meer Steinmeister & Partner opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Ter Meer Steinmeister & Partner

Patent NumberTitleApplicantOpposition DateOpposition Company
EP4054620Glp-1 Receptor Agonists In DementiaNOVO NORDISKFeb 27, 2025GENERICS UK
EP3889181Methods For Treating Atopic Dermatitis By Administering An Il-4R AntagonistSANOFI BIOTECHNOLOGYJan 24, 2025LUIGI
EP2662094Cylodextrin Complexation Methods For Formulating Peptide Proteasome InhibitorsONYX THERAPEUTICSJan 17, 2025TER MEER STEINMEISTER & PARTNER PATENTANWALTE MBB
EP3150200Pharmaceutical Composition, Pharmaceutical Dosage Form, Process For Their Preparation, Methods For Treating And Uses ThereofBOEHRINGER INGELHEIMJan 10, 2025TER MEER STEINMEISTER & PARTNER PATENTANWALTE MBB
EP3302996Security Element Having A Color-Shifting EffectHUECK FOLIEN GESELLSCHAFTJan 10, 2025GIESECKEDEVRIENT CURRENCY TECHNOLOGY
EP3328416Use Of C-Type Natriuretic Peptide Variants To Treat Skeletal DysplasiaBIOMARIN PHARMACEUTICALDec 12, 2024SANDOZ
EP3506915Human Blood-Derived Products Having Decreased Fibrinolytic Activity And Uses Thereof In Hemostatic DisordersPLAS FREEDec 5, 2024BIOTEST
EP3110848Methods For Treating Skin Infection By Administering An Il-4R AntagonistSANOFI BIOTECHNOLOGYNov 14, 2024LUIGI
EP3628319Methods Of Treating Hepatic Encephalopathy Using RifaximinSALIX PHARMACEUTICALSNov 14, 2024HOLLATZ
EP3474820Glp-1 Compositions And Uses ThereofNOVO NORDISKNov 7, 2024GENERICS UK